AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule
QUEBEC CITY, June 15 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported that patient follow-up in the open-label safety study (study 041) of its Phase 3 program in benign prostatic...
Santaris Pharma Delivers Six LNA-Based RNA Inhibitors to Enzon Pharmaceuticals Ahead of Schedule
COPENHAGEN, April 27 /PRNewswire/ -- As a testimony to the strength of
Santaris Pharma's efficient Drug Discovery Engine, the Company announced
today the completion of the delivery of six cancer target drug candidates to
their collaboration partner Enzon Pharmaceuticals. All six drug candidate...
Frost & Sullivan Forecasts Early Rebound: Strong Growth Ahead for Global Economy
MOUNTAIN VIEW, Calif., Feb. 17 /PRNewswire/ -- Frost & Sullivan, the
Growth Partnership Company, reaffirms its position that the economy is
regaining its strength, thanks in part to an unprecedented US $1 trillion
stimulus package from the US government and additional stimulus packages fro...
NeoStem Forges Ahead in Its Plan to Open Adult Stem Cell Collection Centers in Key Locations that Can Serve as Hubs to Service Clients Nationwide
NEW YORK, Aug. 5 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS )
announced today that the new Southern Florida stem cell collection center
located in Coral Gables, a suburb of Miami, is targeted to open in
September. The center is being opened pursuant to an agreement with CelVida
Principle of Recursive Genome Function Supersedes Dogmas; By Andras Pellionisz, Online Ahead of Print; (Scientific Visionary Vindicated)
A Eureka Moment concerning the fractal character of neurons led in turn to a novel picture of genomics where protein structures act back recursively upon their DNA code -- in outright contradiction to prevailing orthodoxy. A household name in neuroscience for his tensor network theory, Dr. ...
Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule
European regulatory authorities support filing strategy
SEATTLE, Dec. 18 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) (Nasdaq and MTAX: CTIC) reported today that it met with and received
feedback from the rapporteur and co-rapporteur regarding its marketing
Human Genome Sciences Completes Enrollment Ahead of Schedule in Second Phase 3 Albuferon(R) Trial
- HGS expects to have all Phase 3 data available by spring 2009 to support
the filing of global marketing authorization applications by fall 2009 -
ROCKVILLE, Md., Nov. 1 /PRNewswire-FirstCall/ -- Human Genome Sciences,
Inc. (Nasdaq: HGSI ) today announced that it has completed enrollment an...
UD researchers race ahead with latest spintronics achievement
In a rapid follow-up to their achievement as the first to demonstrate how an electron's spin can be electrically injected, controlled and detected in silicon, electrical engineers from the University of Delaware and Cambridge NanoTech now show that this quantum property can be transported a marath...
Israeli scientists show bacteria can plan ahead
Bacteria can anticipate a future event and prepare for it, according to new research at the Weizmann Institute of Science. In a paper that appeared today in Nature , Prof. Yitzhak Pilpel, doctoral student Amir Mitchell and research associate Dr. Orna Dahan of the Institute's Molecular Genetics De...
Marshfield Clinic charges ahead in genetic research
Clinics unique position gives it lead in cutting-edge field
MARSHFIELD, WI - TV writers formulating a new drama series on a world-class genetic research laboratory might have problems locating Marshfield on a map of Wisconsin.
But if they wanted a look at what is arguably ground zero for th...
The Year Ahead in IT
Had it not been for the war in Iraq, 2003 might have passed into history as the little year that time forgot. Certainly, in the world of information technology, that may still be the case. Nothing much happened in 2003. Things happened slowly. Customers took their time. But for some activity in the...
Year ahead offers payoff for hard work
First-of-year columns are ripe for prognostication and this one is no different. Like a creaky car on an old wooden roller coaster, the technology industry has been laboring up, up, up the steep incline of recovery. After so much work, the year ahead
will offer a bit of payback, a little joy rid...
Can you keep ahead of progress? An exclusive interview with Rick Smith of iNoc
Rick Smith, the VP of engineering and services at iNoc , doesnt have to worry about getting invited into the boardroom. As one of the companys founders, his participation in setting company direction is a given. While that might not be a strategy for every CIO or IT leader, Ricks situation represe...
Biotech Alliance pushes ahead in SE Wisconsin with likely state funding
A drive to unite the research efforts of southeast Wisconsin received a boost late last week with an approved proposal for $2.5 million in research capital.
The Legislature's Joint Committee on Finance voted 15-1 to provide funding to the Biomedical Technology Alliance, an organization of five u...
Madison wi-fi plans move ahead
Madison, Wis. Web addicts, take heart: A public-private effort is moving toward making downtown Madison one giant wi-fi hotspot.
AOL-SkyCable has been chosen to enter negotiations for the right to provide a wireless Internet service for the general public. The "Wireless Wisconsin" service w...
Merge eFilm corporate merger with Canadian firm moves ahead
Milwaukee The all-stock merger between Merge Technologies Inc., a health-care software and services company, and Canadian firm Cedara Software Corp. will move forward with approval from Merge shareholders.
According to a statement from Merge, company officials expect the merger to be finished...
Google puts new sites on probation, so plan ahead
Wine and cheese arent the only things that get better with age. So do web sites, according to Google.
While its easy to submit new web sites Google, its uncommon for new sites to show up immediately in Googles results. Inexperienced site owners typically assume that the six to 12 month delay ...
Polar neutrino observatory construction leaps ahead
Robert Paulos, associate director for the IceCube project, holds one of the digital optical modules that power the IceCube neutrino telescope. Photo courtesy of the Ice Cube Project. Madison, Wis. An international team of scientists and engineers has taken a major step toward completion of what...
Damn the incumbents, and full speed ahead
The American people should be outraged at getting a second-rate solution for something as critical as its network infrastructure. It goes against what average consumers demand in almost every other product and service arena.
Speed is the common measurement that cuts across many products and se...
Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
... placed to
deliver on our unchanged guidance framework for 2009 and looking ahead
reiterate our aspiration of growing sales in the mid-teens range on aver... physicians to treat Gaucher disease patients with velaglucerase alfa
of commercial availability in the US. Under the conditions of the
Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results
... months ended June 30, 2009 compared with $26.9 million for the same period in 2008.
Voltaren ((R)) Gel: In April 2009, we launched the Go ahead
Rub It In(TM) patient support program which includes assistance with patient co-pays for therapeutic doses of 3 to 5 tubes of Voltaren Gel. The progr...
Neogen Reports 16% Increase in Revenues
... solutions to diverse domestic and international markets has shown some resilience to the economic downturn. We continue to see a world of opportunity ahead
for us, and we will continue to execute the growth strategies necessary to seize the opportunities."
For the first time in any fiscal year, N...
Novavax Announces Repayment of $5 Million of Convertible Debt
...ompany and results in a further strengthening of the balance sheet. Elimination of this debt will allow Novavax to focus on the various opportunities ahead
including continued development of our seasonal flu and H1N1 pandemic flu vaccines as well as the realization of our technology in Spain and India to ...
Dr. Daniel Ronel Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
...ody over time and require repeat injections to maintain wrinkle correction. A skin test is required prior to treatment or approximately four (4) weeks ahead
of time, to ensure a patient is not allergic to the collagen or anesthetic in Artefill.
Artefill is only offered by a select group of physicians...
Asia Debut for Money-Saving Pharma-Packaging Machines from Ireland
...rgest pharmaceutical event in Tokyo on 1-3 July. ahead
of its presence at Interphex, Sepha has already r... mission and believe it is the right time to forge ahead
with its presence there.
...rgest pharmaceutical event in Tokyo on 1-3 July. ahead
of its presence at Interphex, Sepha has already r...
Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide
...Elsevier A&G, study analyst and
webcast presenter. "Not only is Germany not far behind in terms of the number
of papers in this topic group, it is ahead
of the United States when it comes
to the percentage of papers in distinctive competencies. What this indicates
is that there is significant depth to ...
SleepQuest Signs National Contract With Aetna
...d Lori Schulman, SleepQuest's Director of Contracting. "As one of the first national insurers to provide increased access to in-home testing, Aetna is ahead
of the curve."
In addition to home sleep testing, SleepQuest provides initial screening to assure that ambulatory testing is appropriate for each...
PTC Therapeutics Receives $2.6 Million in Government Grants
...across Australia, Canada, Europe, Israel and the United States. PTC announced in February that the study successfully completed enrollment two months ahead
PTC299 is a novel, orally administered small-molecule investigational new drug that inhibits the production of th...
Assessment of safety and efficacy of human embryonic stem cell therapy
...macular degeneration and Stargardt disease, an untreatable form of eye disease that leads to early-onset blindness. The research, which appears online ahead
of print in the journal Stem Cells , shows long-term functional rescue using hESC-derived cells in both the RCS rat and Elov14 mouse, animal models o...
Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data
...t has not previously been possible to correlate virus structures with a virus outbreak or cessation of outbreak, let alone to predict six to 12 months ahead
of the outbreak or its cessation. In 2001, Drs. Samuel and Elenore Bogoch first demonstrated this correlation retrospectively for whole-organism repli...
Healthcare Leaders to Address Patient Safety and Reform at the National Patient Safety Foundation Congress, Washington, DC, May 20-22
...cal patient safety efforts, stating that "the status quo is unsustainable."
IOM Report Retrospective and the Decade ahead
This expert panel will feature distinguished members of the Lucian Leape Institute, including a number of architects of the To Err Is Human re...
10,000 New Jobs, Investments Increased
...ing industry is one of the global heavyweights. Germany is a clear
leader in terms of exports. Chemical companies that produce in Germany can
come out ahead
of the competition in international markets," said Pfeiffer.
In addition to investments by the chemical industry and the related
NovImmune Completes CHF 62.5 (USD 54.8) Million Equity Financing to Move Portfolio Forward and Reacquire Product Rights to Lead Antibodies
...an. With the current financing,
NovImmune now has regained full control of two of its lead compounds from
MerckSerono and is looking forward to moving ahead
with the seven products in
Eduard E. Holdener, MD, Chairman of the Board of Directors, said "This
substantial capital increase ...
Pharmaceutical Packaging Equipment Manufacturer Boosts European Distribution
...orthern Ireland based manufacturer of innovative leak testing and de-blistering equipment, Sepha Ltd is boosting its European distribution network ahead
of its attendance at the world’s leading event for the chemical processing industry. Gearing up to do business at Achema, the major pharmaceutic...
Recombinant C-Reactive Protein
According to Lee Biosolutions President Burton Lee, the company pays close
attention to the clinical research community to stay ahead
of their demands for acute phase proteins like C-Reactive Protein CRP . Lee Biosolution now has canine, rat, human and recombinant c-reactive protein....
The Global Active Pharmaceutical Ingredients (API) Market: A Frost & Sullivan Briefing on Changing Dynamics
...ntries and overcapacity. Market participants will increasingly have to rely on strategies such as capability differentiation and consolidation to stay ahead
of competition," observes Pharmaceutical & Biotechnology Programme Leader Sumanth Kambhammettu from Frost & Sullivan.
Frost & Sulliv...
ViroPharma Incorporated Reports First Quarter 2009 Financial Results
...unt of our senior convertible notes. Cash flow used in operating activities for the three months ended March 31, 2009 was $9.2 million.
ViroPharma is reiterating its guidance for the year 2009 as a convenience to investors. The following guidance provided by ViroPharma...
Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010
...r focus on working capital management, are continuing to drive increased cash balances, cash flows from operations and return on invested capital well ahead
of expectations. Our balance sheet is stronger than ever, which provides us with increased flexibility to deploy capital to drive long-term shareholde...
Medicago initiates work on Swine Flu strain
... and Genetic Therapies Directorate ("BGTD"). Based on the outcome of the meeting, the Company is finalising pre-clinical studies and preparing to move ahead
with the submission of a CTA for its lead H5N1 pandemic VLP vaccine and with final approval will initiate a Phase I clinical trial in the third quarte...
Xspray Expands to Meet Pharma's Interest in its Ground-Breaking Particle Production Technology
...and analysis capabilities. Plus, we
will be opening our new GMP production facility within the next month or so.
There are some exciting opportunities ahead
for Xspray, so it is important
that we have a capable, dynamic organization in place to take full advantage